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Evolution of serum phosphate in long intermittent hemo- tent HD and compare these parameters between conven-
dialysis. tional (CHD) and long HD (LHD).
Background. Phosphate (P) control is crucial to prevent sec-
ondary hyperparathyroidism and extraosseous calcification.
Hemodialysis techniques normally used do not remove the METHODSamount of P absorbed from an adequate protein intake. Our
long hemodialysis (LHD) procedure produces greater P re- Dialysis schedule
moval in a seven-hour session than in a conventional four-hour LHD was performed thrice weekly at night, each ses-session. Our aim was to assess the evolution of predialysis
sion lasting for seven hours. Blood flow was 200 to 250serum P and Ca x P product in patients on intermittent LHD
mL/min. The dialyzer surface was initially 1.0 m2, butduring the first two years on this dialysis schedule.
Methods. Eight irregular compliant patients underwent soon increased to 1.3 to 1.6m2. Bicarbonate buffer pre-
LHD for 12 months; five of them completing 24 months. In scribed was 30 mEq/L. The previous CHD schedule was
the conventional hemodialysis (CHD) period, session time was
thrice weekly, four hours per session, blood flow 30012 hours per week, while it was 21 hours per week in LHD.
mL/min, dialyzer surface 1.3 to 1.6 m2, bicarbonate bufferWe compared P and Ca x P product throughout both periods;
each patient was his or her own control. 35 mEq/L.
Results. Mean serum P improved from 7.1  1.1 mg/dL in In both periods, patients were dialyzed with polysul-
CHD to 5.6 1.1 mg/dL during the second year on LHD (P fone membrane, dialysate calcium 3 mEq/L, and dialy-0.05). Mean Ca x P product decreased from 64  12.7 mg2/dL2
sate flow 500 mL/min. Mean urea Kt/V was 1.12 in CHDduring CHD to 50.9  10.3 mg2/dL2 at the end of the second
and 1.60 in LHD. Arteriovenous (AV) fistula was uti-year of LHD.
Conclusion. By prolonging dialysis time to 21 hours per lized in both periods.
week, better P serum control and lower Ca x P product were
achieved in our patients. Patients
We studied eight in-center patients aged 38 14 years
who had been enrolled for at 12 months in LHD; 5 ofInadequate phosphate (P) control and elevated cal-
them completed 24 months. The patients had been oncium phosphorous product (Ca x P) can lead to severe
CHD 51  39 months before switching to LHD. Thehyperparathyroidism and harmful extraosseous calcifi-
prescribed diet protein was 1.2 g/kg/day and diet P wascation risk in dialysis patients. Hyperphosphatemia and
1000 to 1200 mg/day. However, we must remark thatelevated Ca x P product are strong predictors of cardio-
these patients were noncompliant with the diet prescrip-vascular mortality in these patients[1].
tion.Although dietary P restriction and calcium-based P
Calcium-based P binders were cautiously used in onebinders have been undertaken to improve serum P and
patient because of risk of hypercalcemia; other patientsCa x P product in chronic renal failure, malnutrition
did not adhere to their P binder regimen. At the begin-and Ca overload must not be underestimated, becoming
ning of LHD, six patients had intact parathyroid hor-crucial during dialysis for P removal [2]. Therefore, alter-
mone (PTH) dosage available: five had mild and onenative hemodialysis (HD) regimens have been used to
had moderate hyperparathyroidism (HPT). Only oneincrease P removal: short daily HD, long intermittent
patient was under irregular calcitriol treatment.HD, and daily long nocturnal HD.
This study considered the previous six months of theOur aim was to assess pre-HD serum P and Ca x P
CHD period and the first 12 and 24 months of the LHDproduct in patients undergoing long nocturnal intermit-
period. Serum Ca, P, alkaline phosphatase activity, and
intact PTH were analyzed.
Key words: Ca x P product, dialysis time, hyperphosphatemia. Paired Student t test was used to compare both dialysis
periods and each patient was his or her own control. 2003 by the International Society of Nephrology
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Table 1. Serum calcium, phosphate and Ca x P during conventional and long hemodialysis
N P mg/dL Mean (SD) Ca mg/dL Mean (SD) Ca x P Mean (SD)
CHD 8 7.1 (1.1) 8.9 (0.8) 64.2 (12.7)
1st semester 8 6.4 (1.4)a 9.1 (0.7) 61.6 (13.4)
2nd semester 8 6.0 (1.4)b 9.3 (0.9)a 56.9 (15.1)a
3rd semester 5 6.4 (1.2) 9.4 (0.7)b 51.4 (12.7)
4th semester 5 5.6 (1.1)b 9.4 (0.8)a 50.9 (10.3)a
CHD is the last six months in conventional hemodialysis. 1st, 2nd, 3rd, and 4th semesters in long hemodialysis period. Data are expresed as meanSD.
a P  0.05 compared with CHD
b P  0.001 compared with CHD
D derivatives: one patient with moderate secondary
HPT, and one patient who developed postparathyroidec-
tomy recurrence of HPT.
DISCUSSION
P removal in dialysis may be influenced by several
factors: pre-HD serum P, dialyzer surface, blood flow,
dialysis time, frequency of dialysis, and controversial acid
base metabolism [3, 4].
P is preferentially found intracellularly and its slow
diffusion across cellular membrane barriers, unlike urea,
makes elimination by dialysis extremely dependent upon
Fig. 1. Changes in individual predialysis P during conventional (CHD)
duration of the procedure. Prolonging time in dialysisand two years of long nocturnal hemodialysis (LHD). CHD: mean of
last six months; LHD: three-month mean values. () expresses mean allows P to be transferred from the intracellular to the
of the patient group. extracellular compartment and be directly available for
dialytic removal [5]. Recently, a four-pool P model was
proposed, making P kinetics even more complex [6].
Experiences of Pierratos et al [7, 8] in daily long noc-RESULTS
turnal HD and Tassin regimen with long intermittentMean predialysis serum P decreased significantly
HD, have demonstrated that longer dialysis offers advan-throughout the study period (Fig. 1). During CHD, seven
tages over conventional methods in achieving better se-of the eight patients had their serum P above 6 mg/dL
rum P control. Even more, patients undergoing daily(mean  7.1  1.1 mg/dL). Throughout the first year on
long nocturnal HD are off P binders, and P addition inLHD, predialysis serum P decreased to 6  1.4 mg/dL
the dialysate is needed [9].(P  0.001) (Table 1). Five patients reached better P
In a previous study (unpublished personal data, 1998),control, with mean serum P 6.2 mg/dL. By the second
we assessed P removal by collecting the total dialysateyear of the study, all five patients who continued LHD
spent during one session. We found greater P removal inreduced serum P. Three of them had predialysis P values
a seven-hour dialysis session than in a four-hour dialysisof 5.6 mg/dL (P  0.001).
session (1541  555 mg vs. 806  180 mg; P  0.04),Serum calcium concentrations increased during follow
and P was removed throughout the seven hours. Weup, from 8.9  0.8 mg/dL in the CHD period to 9.4 
demonstrated that long HD was able to completely ex-0.8 mg/dL within two years.
tract the phosphate extracellular pool and part of theCa x P product was 64.2  12.7 mg2/dL2, decreasing
intracellular pool, as well.to 56.9  15.1 mg2/dL2 at the end of the first year (P 
0.05), and 50.9  10.3 mg2/dL2 at the end of the second
year on LHD (P  0.05). This decrease was due to the
CONCLUSIONimprovement in serum P as serum Ca increased over
In our experience with intermittent long nocturnaltime.
hemodialysis, better P control was observed after a six-There was no significant difference in alkaline phos-
month period, with a continuous improvement in thephatase activity throughout the study period.
following 18 months. As a consequence, Ca x P decreasedSerum intact PTH concentrations showed great vari-
and allowed us to treat secondary HPT in two patientsability, with a downward trend along the study period.
Better serum P control allowed us to treat with vitamin with vitamin D derivatives.
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